Table 2.
Relations between pathologic findings and MR staging
| MRI | (%) | Microscopy | (%) | |
|---|---|---|---|---|
| Maximal tumor length | ||||
| Median (mm) (range) | 19 (10–43) | 24 (7–55) | ||
| Maximal tumor radius | ||||
| Median (mm) (range) | 14 (4–28) | 13 (3–29) | ||
| Maximal tumor diameter | ||||
| Median (mm) (range) | 30 (10–43) | 26 (7–55) | ||
| Positive parametrial invasion | 7 | 23% | 4 | 13% |
| Positive lymph node metastases | 1 | 3% | 5a | 17% |
| Positive vaginal invasion | 2 | 6% | 5 | 16% |
| Stage (FIGO) | ||||
| Ia | 1 | 3% | 2 | 6% |
| Ib1 | 22 | 71% | 14 | 45% |
| Ib2 | 0 | 0% | 9 | 29% |
| IIa | 1 | 3% | 3 | 10% |
| IIb | 7 | 23% | 3 | 10% |
aAmong those with lymph node dissection (n = 29).
Maximal tumor length, defined as the longitudinal tumor size along with an assumed tandem applicator
Maximal tumor radius, defined as the longest tumor radius measured around an assumed tandem applicator in the axial, coronal or sagittal plane.